While not affecting MCF-10A normal breast epithelial cell proliferation, our results indicate that β-D-glucan inhibits breast cancer cell proliferation and modulates gene expression independent of ERα activity and may be useful for inhibiting endocrine-resistant breast cancer cell proliferation. The gene discussed is ESR1; the disease is breast cancer.